摘要
目的：探讨分析阿托伐他汀治疗急性冠脉综合征强化调脂的临床疗效和安全性。方法回顾性分析2012年1月至2013年5月间在我院进行治疗的106例急性冠脉综合征合并高血脂症患者的临床记录资料。结果治疗后，观察组的TC、LDLC 水平明显低于对照组，具有统计学差异（ P ＜0．05）；观察组的不良反应发生率为20．75％，和对照组的15．09％相比，无统计学差异（P＞0．05）。结论阿托伐他汀治疗急性冠脉综合征的临床疗效显著，安全性高，值得临床推广应用。
Abstract
Objective To investigate clinical efficacy and safety of atorvastatin in treatment for acute coronary syndrome .Methods Clinical record data of 106 cases of acute coronary syndrome patients with combined hyperlipidemia in our hospital from January 2012 to May 2013 were reviewed.Results After treatment,the TC,LDLC levels of observation group were significantly lower than that of the control group,with a significant difference(P<0.05).The adverse reactions incidence of observation group was 20.75%,and compared to that of the control group(15.09%)(P>0.05).Conclusion Atorvastatin treatment of acute coronary syndrome have significant clinical efficacy,safety and is worthy of clinical application.
NETL
NSTL
万方数据